{
  "compound": "Smoked cannabis",
  "condition": "PARKINSONS",
  "effect_size": "Very large (d = 1.42)",
  "study_type": "OBSERVATIONAL",
  "source": "NORML:PD_OBSERVATIONAL_001",
  "participants": "22 PD patients",
  "year": 2014,
  "notes": "Medical Cannabis for Parkinson's Disease: Open-Label Prospective Study",
  "confidence": "medium",
  "abstract": "Mean UPDRS improvement: 27.9\u219217.5 (37% reduction, p<0.001); Tremor reduced 44%; Rigidity reduced 31%; Bradykinesia reduced 35%"
}